Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma

Journal of Hepatology

Volumn 42, Issue 5, 2005, Pages 728-735

  Stefani, Anna Lisa ^a   Barzon, Luisa ^a   Castagliuolo, Ignazio ^a   Guido, Maria ^a   Pacenti, Monia ^a   Parolin, Cristina ^a   Farinati, Fabio ^a   Palù, Giorgio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; INTERLEUKIN 2; RETROVIRUS VECTOR; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL KILLING; CONTROLLED STUDY; DNA MICROARRAY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUICIDE GENE; TUMOR; TUMOR REGRESSION; UPREGULATION; VIRAL GENE THERAPY;

EID: 17044398835     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.12.037     Document Type: Article

References (27)

1. K. Okuda Hepatocellular carcinoma J Hepatol 32 2000 225 237
2. D.F. Schafer, and M.F. Sorrell Hepatocellular carcinoma Lancet 353 1999 1253 1257
3. E.A. Akriviadis, J.M. Llovet, and S.C. Efremidis Hepatocellular carcinoma Br J Surg 85 1998 1319 1331
4. J. Bruix, M. Sherman, J.M. Llovet, M. Beaugrand, R. Lencioni, and A.K. Burroughs Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
5. A.S. Yu, and E.B. Keeffe Management of hepatocellular carcinoma Rev Gastroenterol Disord 3 2003 8 24
6. Sangro B, Herraiz M, Prieto J. Gene therapy of neoplastic liver diseases. Int J Biochem Cell Biol. 2003; 35: 135-148.
7. M. Caruso, Y. Panis, S. Gagandeep, D. Houssin, J.L. Salzmann, and D. Klatzmann Regression of established macroscopic liver metastases after in situ transduction of a suicide gene Proc Natl Acad Sci USA 90 1993 7024 7028
8. D. Barba, J. Hardin, M. Sadelain, and F.H. Gage Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors Proc Natl Acad Sci USA 9 1994 4348 4352
9. S.M. Freeman, R. Ramesh, M. Shastri, A. Munshi, A.K. Jensen, and A.J. Marrogi The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells Cancer Lett 92 1995 167 174
10. S. Chouaib, C. Asselin-Paturel, F. Mami-Chouaib, A. Caignard, and J.Y. Blay The host-tumor immune conflict: from immunosuppression to resistance and destruction Immunol Today 18 1997 493 497
11. L. Barzon, M. Boscaro, and G. Palù Endocrine aspects of cancer gene therapy Endocr Rev 25 2004 1 44
12. G. Palù, A. Cavaggioni, Calvi, E. Franchin, M. Pizzato, and R. Boschetto Gene therapy of glioblastoma multiforme via combined expression of suicide and cytochine genes: a pilot study in humans Gene Ther 6 1999 330 337
13. L. Barzon, A. Taccaliti, E. Franchin, M. Pacenti, M. Boscaro, and G. Palù Suicide/cytokine gene therapy in end-stage anaplastic thyroid carcinoma Mol Ther 5 2002 S386
14. M. Pizzato, E. Franchin, P. Calvi, R. Boschetto, M. Colombo, and S. Ferrini Production and characterization of a bicistronic Moloney-based vector expressing human interleukin-2 and herpes simplex virus thymidine kinase for gene therapy of cancer Gene Ther 5 1998 1003 1007
15. L. Barzon, R. Bonaguro, I. Castagliuolo, M. Chilosi, E. Franchin, and C. Del Vecchio Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase Eur J Endocrinol 148 2003 73 80
16. I. Giaretta, D. Madeo, R. Bonaguro, A. Cappellari, F. Rodeghiero, and G. Palù A comparative evaluation of gene transfer into blood cells using the same retroviral backbone for independent expression of the EGFP and deltaLNGFR marker genes Haematologica 85 2000 680 689
17. W.J. Krall, D.C. Skelton, X.J. Yu, I. Riviere, P. Lehn, and R.C. Mulligan Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells Gene Ther 3 1996 37 48
18. J. Byun, S.H. Kim, J.M. Kim, S.S. Yu, P.D. Robbins, and J. Yim Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy Gene Ther 3 1996 780 788
19. G. Palmieri, L. Montella, M. Milo, R. Fiore, E. Biondi, and A.R. Bianco Ultra-low-dose interleukin-2 in unresectable hepatocellular carcinoma Am J Clin Oncol 25 2002 224 226
20. S.H. Chen, K. Kosai, B. Xu, K. Pham-Nguyen, C. Contant, and M.J. Finegold Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival Cancer Res 56 1996 3758 3762
21. A.S. Majumdar, A. Zolotorev, S. Samuel, K. Tran, B. Vertin, and M. Hall-Meier Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model Cancer Gene Ther 7 2000 1086 1099
22. M.N. Soler, G. Milhaud, F. Lekmine, F. Treilhou-Lahille, D. Klatzmann, and S. Lausson Treatment of medullary thyroid carcinoma by combined expression of suicide and interleukin-2 genes Cancer Immunol Immunother 48 1999 91 99
23. D.G. Brockstedt, M. Diagana, Y. Zhang, K. Tran, N. Belmar, and M. Meier Development of anti-tumor immunity against a non-immunogenic mammary carcinoma through in vivo somatic GM-CSF, IL-2, and HSVtk combination gene therapy Mol Ther 6 2002 627 636
24. A. Alves, L. Charre, Y. Panis, J. Cardoso, M. Fabre, and E. Brisson Total vascular exclusion of the liver enhances the efficacy of retroviral-mediated associated thymidine kinase and interleukin-2 genes transfer against multiple hepatic tumors in rats Surgery 133 2003 669 677
25. S.Y. Guo, Q.L. Gu, Z.G. Zhu, H.Q. Hong, and Y.Z. Lin TK gene combined with mIL-2 and mGM-CSF genes in treatment of gastric cancer World J Gastroenterol 9 2003 233 237
26. M. Yamazaki, F.H. Straus, M. Messina, B.G. Robinson, T. Takeda, and K. Hashizume Adenovirus-mediated tumor-specific combined gene therapy using herpes simplex virus thymidine/ganciclovir system and murine interleukin-12 induces effective antitumor activity against medullary thyroid carcinoma Cancer Gene Ther 11 2004 8 15
27. C. Engelmann, J.M. Heslan, M. Fabre, J.P. Lagarde, D. Klatzmann, and Y. Panis Importance, mechanisms and limitations of the distant bystander effect in cancer gene therapy of experimental liver tumors Cancer Lett 179 2002 59 69